Effects of Berberine on Gut Microbiota in Patients with Mild Metabolic Disorders Induced by Olanzapine
Authors:
- 1 January 2021
- journal article
- research article
- Published by World Scientific Pub Co Pte Ltd in The American Journal of Chinese Medicine
- Vol. 49 (08) , 1949-1963
Abstract
Secondary metabolic disturbances in patients with schizophrenia or bipolar disorder may be attributed to olanzapine. It is important to prevent mild metabolic disorders progressing to metabolic syndrome. This study aims to investigate the effects of berberine on intestinal flora in patients with mild metabolic disorders induced by olanzapine. A total of 132 patients with schizophrenia, bipolar disorder, or schizoaffective psychosis that had been treated with olanzapine for at least 9 months were randomly assigned ( = 66 each) to receive berberine or placebo tablets for 12 weeks. Metabolic assessments and intestinal flora were quantified at baseline and after 4, 8, and 12 weeks of treatment. Incidence rates of adverse reactions were recorded. FPG, FPI, HOMA-IR, HbA1, TG, BMI, and WC were significantly lower in patients who received berberine compared to placebo after 12 weeks of treatment ( < 0.05). The abundance of firmicutes and coliform were significantly lower and the abundance of bacteroides significantly higher in patients who received berberine compared to placebo after 12 weeks of treatment ( < 0.05). In patients who received berberine, the abundance of firmicutes was significantly decreased, and the abundance of bacteroides was significantly increased, and in patients who received placebo, the abundance of firmicutes was significantly increased post-treatment, compared to baseline (both < 0.05). In conclusions, berberine may regulate intestinal flora and metabolism in patients with schizophrenia or bipolar disorder and mild metabolic disturbances induced by olanzapine.
Keywords
Funding Information
- Key Subject funds of Tongxiang (201901012)
- Science and Technology Planning Project of Tongxiang (201603080)
This publication has 53 references indexed in Scilit:
- Current knowledge and pharmacological profile of berberine: An updateEuropean Journal of Pharmacology, 2015
- Differences in the gut microbiota of healthy children and those with type 1 diabetesPediatrics International, 2014
- Fecal microbiota imbalance in Mexican children with type 1 diabetesScientific Reports, 2014
- Gut metagenome in European women with normal, impaired and diabetic glucose controlNature, 2013
- Transfer of Intestinal Microbiota From Lean Donors Increases Insulin Sensitivity in Individuals With Metabolic SyndromeGastroenterology, 2012
- Structural Changes of Gut Microbiota during Berberine-Mediated Prevention of Obesity and Insulin Resistance in High-Fat Diet-Fed RatsPLOS ONE, 2012
- A patient perspective of the impact of medication side effects on adherence: results of a cross-sectional nationwide survey of patients with schizophreniaBMC Psychiatry, 2012
- Inhibition of Type 1 Diabetes Correlated to a Lactobacillus johnsonii N6.2-Mediated Th17 BiasThe Journal of Immunology, 2011
- Synergistic effect of phytochemicals in combination with hypoglycemic drugs on glucose uptake in myotubesPhytomedicine, 2009
- The gut microbiota as an environmental factor that regulates fat storageProceedings of the National Academy of Sciences, 2004